OTCMKTS:GNOW

American Caresource Competitors

$0.0075
-0.01 (-62.31 %)
(As of 04/14/2021 03:47 PM ET)
Add
Compare
Today's Range
$0.01
Now: $0.01
$0.02
50-Day Range
$0.01
MA: $0.01
$0.03
52-Week Range
$0.00
Now: $0.01
$0.07
Volume22,800 shs
Average Volume63,980 shs
Market Capitalization$124,477.50
P/E RatioN/A
Dividend YieldN/A
Beta2.56

Competitors

American Caresource (OTCMKTS:GNOW) Vs. FMS, DVA, SHC, PGNY, TVTY, and TLMD

Should you be buying GNOW stock or one of its competitors? Companies in the industry of "miscellaneous health & allied services, not elsewhere classified" are considered alternatives and competitors to American Caresource, including Fresenius Medical Care AG & Co. KGaA (FMS), DaVita (DVA), Sotera Health (SHC), Progyny (PGNY), Tivity Health (TVTY), and SOC Telemed (TLMD).

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) and American Caresource (OTCMKTS:GNOW) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, analyst recommendations, profitability, valuation, earnings, risk and institutional ownership.

Analyst Ratings

This is a summary of recent recommendations and price targets for Fresenius Medical Care AG & Co. KGaA and American Caresource, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Fresenius Medical Care AG & Co. KGaA19702.35
American Caresource0000N/A

Fresenius Medical Care AG & Co. KGaA presently has a consensus target price of $45.00, suggesting a potential upside of 19.43%. Given Fresenius Medical Care AG & Co. KGaA's higher probable upside, equities analysts plainly believe Fresenius Medical Care AG & Co. KGaA is more favorable than American Caresource.

Profitability

This table compares Fresenius Medical Care AG & Co. KGaA and American Caresource's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Fresenius Medical Care AG & Co. KGaA7.38%10.62%4.15%
American CaresourceN/AN/AN/A

Insider and Institutional Ownership

1.6% of Fresenius Medical Care AG & Co. KGaA shares are held by institutional investors. 51.5% of American Caresource shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Earnings and Valuation

This table compares Fresenius Medical Care AG & Co. KGaA and American Caresource's revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Fresenius Medical Care AG & Co. KGaA$19.58 billion1.13$1.34 billion$2.5314.89
American CaresourceN/AN/AN/AN/AN/A

Fresenius Medical Care AG & Co. KGaA has higher revenue and earnings than American Caresource.

Volatility & Risk

Fresenius Medical Care AG & Co. KGaA has a beta of 1.21, indicating that its stock price is 21% more volatile than the S&P 500. Comparatively, American Caresource has a beta of 2.56, indicating that its stock price is 156% more volatile than the S&P 500.

Summary

Fresenius Medical Care AG & Co. KGaA beats American Caresource on 7 of the 9 factors compared between the two stocks.

American Caresource (OTCMKTS:GNOW) and DaVita (NYSE:DVA) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, profitability, earnings, analyst recommendations, valuation, institutional ownership and risk.

Analyst Recommendations

This is a breakdown of recent ratings and price targets for American Caresource and DaVita, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
American Caresource0000N/A
DaVita13102.00

DaVita has a consensus price target of $114.60, suggesting a potential upside of 5.89%. Given DaVita's higher probable upside, analysts plainly believe DaVita is more favorable than American Caresource.

Profitability

This table compares American Caresource and DaVita's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
American CaresourceN/AN/AN/A
DaVita7.32%43.99%5.27%

Institutional and Insider Ownership

91.7% of DaVita shares are owned by institutional investors. 51.5% of American Caresource shares are owned by company insiders. Comparatively, 1.0% of DaVita shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Valuation & Earnings

This table compares American Caresource and DaVita's top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
American CaresourceN/AN/AN/AN/AN/A
DaVita$11.39 billion1.04$810.98 million$5.4020.04

DaVita has higher revenue and earnings than American Caresource.

Volatility and Risk

American Caresource has a beta of 2.56, suggesting that its share price is 156% more volatile than the S&P 500. Comparatively, DaVita has a beta of 1.3, suggesting that its share price is 30% more volatile than the S&P 500.

Summary

DaVita beats American Caresource on 7 of the 9 factors compared between the two stocks.

American Caresource (OTCMKTS:GNOW) and Sotera Health (NYSE:SHC) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, profitability, earnings, analyst recommendations, valuation, institutional ownership and risk.

Analyst Recommendations

This is a breakdown of recent ratings and price targets for American Caresource and Sotera Health, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
American Caresource0000N/A
Sotera Health001003.00

Sotera Health has a consensus price target of $32.75, suggesting a potential upside of 26.30%. Given Sotera Health's higher probable upside, analysts plainly believe Sotera Health is more favorable than American Caresource.

Profitability

This table compares American Caresource and Sotera Health's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
American CaresourceN/AN/AN/A
Sotera HealthN/AN/AN/A

Valuation & Earnings

This table compares American Caresource and Sotera Health's top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
American CaresourceN/AN/AN/AN/AN/A
Sotera HealthN/AN/AN/AN/AN/A

Summary

Sotera Health beats American Caresource on 2 of the 2 factors compared between the two stocks.

American Caresource (OTCMKTS:GNOW) and Progyny (NASDAQ:PGNY) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, profitability, earnings, analyst recommendations, valuation, institutional ownership and risk.

Analyst Recommendations

This is a breakdown of recent ratings and price targets for American Caresource and Progyny, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
American Caresource0000N/A
Progyny00603.00

Progyny has a consensus price target of $38.8333, suggesting a potential downside of 22.10%. Given Progyny's higher probable upside, analysts plainly believe Progyny is more favorable than American Caresource.

Profitability

This table compares American Caresource and Progyny's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
American CaresourceN/AN/AN/A
Progyny1.03%7.43%5.04%

Institutional and Insider Ownership

58.5% of Progyny shares are owned by institutional investors. 51.5% of American Caresource shares are owned by company insiders. Comparatively, 33.3% of Progyny shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Valuation & Earnings

This table compares American Caresource and Progyny's top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
American CaresourceN/AN/AN/AN/AN/A
Progyny$229.68 million18.93$-8,570,000.00$0.11453.18

American Caresource has higher earnings, but lower revenue than Progyny.

Volatility and Risk

American Caresource has a beta of 2.56, suggesting that its share price is 156% more volatile than the S&P 500. Comparatively, Progyny has a beta of 1.83, suggesting that its share price is 83% more volatile than the S&P 500.

Summary

Progyny beats American Caresource on 7 of the 9 factors compared between the two stocks.

American Caresource (OTCMKTS:GNOW) and Tivity Health (NASDAQ:TVTY) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, profitability, earnings, analyst recommendations, valuation, institutional ownership and risk.

Volatility and Risk

American Caresource has a beta of 2.56, suggesting that its share price is 156% more volatile than the S&P 500. Comparatively, Tivity Health has a beta of 2.49, suggesting that its share price is 149% more volatile than the S&P 500.

Profitability

This table compares American Caresource and Tivity Health's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
American CaresourceN/AN/AN/A
Tivity Health-47.44%128.43%6.11%

Analyst Recommendations

This is a breakdown of recent ratings and price targets for American Caresource and Tivity Health, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
American Caresource0000N/A
Tivity Health12502.50

Tivity Health has a consensus price target of $22.1250, suggesting a potential downside of 5.33%. Given Tivity Health's higher probable upside, analysts plainly believe Tivity Health is more favorable than American Caresource.

Valuation & Earnings

This table compares American Caresource and Tivity Health's top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
American CaresourceN/AN/AN/AN/AN/A
Tivity Health$1.13 billion1.02$-286,820,000.00$2.0211.57

American Caresource has higher earnings, but lower revenue than Tivity Health.

Institutional and Insider Ownership

91.6% of Tivity Health shares are owned by institutional investors. 51.5% of American Caresource shares are owned by company insiders. Comparatively, 11.8% of Tivity Health shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Summary

Tivity Health beats American Caresource on 6 of the 9 factors compared between the two stocks.

American Caresource (OTCMKTS:GNOW) and SOC Telemed (NASDAQ:TLMD) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, dividends, profitability, earnings, analyst recommendations, risk and institutional ownership.

Profitability

This table compares American Caresource and SOC Telemed's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
American CaresourceN/AN/AN/A
SOC TelemedN/AN/AN/A

Analyst Ratings

This is a summary of recent ratings and recommmendations for American Caresource and SOC Telemed, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
American Caresource0000N/A
SOC Telemed01502.83

SOC Telemed has a consensus price target of $11.40, suggesting a potential upside of 67.89%. Given SOC Telemed's higher probable upside, analysts clearly believe SOC Telemed is more favorable than American Caresource.

Earnings and Valuation

This table compares American Caresource and SOC Telemed's top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
American CaresourceN/AN/AN/AN/AN/A
SOC TelemedN/AN/A$20,000.00N/AN/A

Institutional & Insider Ownership

20.7% of SOC Telemed shares are owned by institutional investors. 51.5% of American Caresource shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Summary

SOC Telemed beats American Caresource on 3 of the 4 factors compared between the two stocks.


American Caresource Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
Fresenius Medical Care AG & Co. KGaA logo
FMS
Fresenius Medical Care AG & Co. KGaA
1.7$37.68-0.4%$22.07 billion$19.58 billion14.95
DaVita logo
DVA
DaVita
1.7$108.23-0.7%$11.84 billion$11.39 billion16.23
Sotera Health logo
SHC
Sotera Health
2.0$25.93-0.3%$7.34 billionN/A0.00Analyst Upgrade
Progyny logo
PGNY
Progyny
1.5$49.85-3.7%$4.35 billion$229.68 million453.18
Tivity Health logo
TVTY
Tivity Health
1.0$23.37-1.2%$1.15 billion$1.13 billion-2.11News Coverage
SOC Telemed logo
TLMD
SOC Telemed
1.6$6.79-0.1%$608.55 millionN/A0.00
Ontrak logo
OTRK
Ontrak
1.7$31.29-2.7%$553.52 million$35.10 million-18.41
Viemed Healthcare logo
VMD
Viemed Healthcare
1.1$9.75-2.4%$382.05 million$80.26 million13.54News Coverage
HemaCare logo
HEMA
HemaCare
0.5$25.31-0.6%$346.52 millionN/A0.00News Coverage
Caladrius Biosciences logo
CLBS
Caladrius Biosciences
1.5$1.61-0.0%$95.79 millionN/A-2.52Decrease in Short Interest
Baudax Bio logo
BXRX
Baudax Bio
1.4$1.13-2.7%$79.26 millionN/A-0.32Increase in Short Interest
Cryo-Cell International logo
CCEL
Cryo-Cell International
0.9$9.75-1.5%$73.82 million$31.80 million24.38
GRNV
GreenVision Acquisition
0.3$10.18-0.0%$73.17 millionN/A0.00Increase in Short Interest
Emmaus Life Sciences logo
EMMA
Emmaus Life Sciences
0.2$1.35-0.0%$66.13 million$1.32 million0.00
CTYX
Curative Biotechnology
0.0$0.15-0.1%$61.66 millionN/A0.00Decrease in Short Interest
Gap Down
PFHOD
Pacific Health Care Organization
0.5$1.25-228.0%$52.48 million$6.80 million0.00Gap Up
BRTXQ
BioRestorative Therapies
0.0$0.01-0.0%$18.86 million$110,000.00-0.01
BioRestorative Therapies logo
BRTX
BioRestorative Therapies
0.6$0.01-0.0%$18.85 million$110,000.000.00Decrease in Short Interest
PFHO
Pacific Health Care Organization
0.8$1.14-0.9%$14.53 million$7.33 million0.00High Trading Volume
HYBE
Hybrid Energy
0.0$0.00-0.0%$0.00N/A0.00Increase in Short Interest
News Coverage
Gap Down
QMED
QMed
0.2$0.00-0.0%$0.00N/A0.00
This page was last updated on 4/15/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.